PTHL

MKT CAP:$4M

Pheton Holdings Ltd Class A Ordinary Shares

Market Cap

$4M

Healthcare·Medical - Devices·🇨🇳 China·NASDAQ

Healthcare·Medical - Devices·🇨🇳·NASDAQ

Stock Price

$0.32-$0.12 (-26.98%)

Mar 16, 2026

Company Details

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer pati...

CEO

Jianfei Zhang

IPO Date

Sep 5, 2024

Website

www.ftzy.com.cn

Key Metrics TTM

Revenue

$880.7K

— YoY

Net Income

-$2M

EPS (Diluted)

-$0.14

Free Cash Flow

-$3M

Revenue / Share

$0.06

Gross Margin

80.7%

Operating Margin

-238.5%

Net Margin

-226.6%

FCF Margin

-337.3%

P/S

4.6x

P/E

—

Earnings Reports

Q2 2025

Dec 16, 2025

$67.5KEPS -$0.14

FY 2024

Mar 20, 2025

$448.2K-28.7%EPS -$0.05

FY 2023

Dec 31, 2023

$628.6K-7.5%EPS -$0.02

Q2 2023

Jun 30, 2023

$133.4K-65.6%EPS -$0.01

FY 2022

Dec 31, 2022

$679.8K-3.3%EPS $0.01

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 21	$351.4K	$295.4K	$69.0K
Q4 21	$351.4K	$295.4K	$69.0K
Q2 22	$387.3K	$334.9K	$61.6K
Q4 22	$292.5K	$223.3K	-$34.1K
Q2 23	$133.4K	$99.5K	-$47.2K
Q2 25	$67.5K	$53.3K	-$2M

Valuation

Quarter	P/S	P/E
Q2 21	—	—
Q4 21	—	—
Q2 22	—	—
Q4 22	3.0x	14.8x
Q2 23	3.5x	29.6x
Q2 25	4.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 21	$40.4K	$40.4K
Q4 21	$40.4K	$40.4K
Q2 22	-$160.1K	-$160.1K
Q4 22	$44.0K	$44.0K
Q2 23	-$15.4K	-$15.4K
Q2 25	-$3M	-$3M

Capital Expenditures

Quarter	CapEx
Q2 21	$0
Q4 21	$0
Q2 22	$0
Q4 22	$3
Q2 23	$3
Q2 25	$2.7K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 23	-62.0%	-36.0%
Q2 25	-80.8%	+660.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 21	$0	0.0%
Q4 21	$0	0.0%
Q2 22	$0	0.0%
Q4 22	$0	0.0%
Q2 23	$0	0.0%
Q2 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q2 21	$40.6K	$83.1K	$102.6K	—
Q4 21	$40.6K	$83.1K	$102.6K	—
Q2 22	$26.1K	—	—	$247.2K
Q4 22	$47.6K	—	—	$209.8K
Q2 23	$19.0K	$41.4K	$72.7K	—
Q2 25	$35.6K	—	—	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 21	$136.8K	$0	$136.8K
Q2 22	$35.1K	$0	$35.1K
Q4 22	$72.3K	$0	$72.3K
Q2 23	$33.5K	$0	$33.5K
Q4 23	$217.9K	$0	$217.9K
Q2 24	$17.9K	$0	$17.9K
Q4 24	$6M	$0	$6M
Q2 25	$2M	$1M	$3M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 21	7M	—	—
Q4 21	7M	0.0%	—
Q2 22	15M	+112.2%	—
Q4 22	15M	0.0%	—
Q2 23	15M	0.0%	+112.2%
Q2 25	15M	+3.5%	+119.7%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 21	—	—
Q4 21	—	—
Q2 22	—	—
Q4 22	—	—
Q2 23	—	—
Q2 25	$1	100K

Revenue / Employee